Apple Wins US Tribunal Ruling, Avoids Fresh Import Ban on Redesigned Watches
Updated
Updated · Tom's Guide · Apr 21
Apple Wins US Tribunal Ruling, Avoids Fresh Import Ban on Redesigned Watches
29 articles · Updated · Tom's Guide · Apr 21
Apple has avoided a renewed import ban on its smartwatches after the US International Trade Commission ruled in its favour against Masimo.
The tribunal found that Apple’s redesigned blood-oxygen monitoring technology does not infringe Masimo’s patents, allowing sales to continue in the US.
This decision follows years of legal disputes, though Masimo can still appeal; other lawsuits between the companies remain ongoing.
How did Apple's software redesign convince the ITC its new watches don't infringe Masimo's patents?
Will Apple still have to pay the separate $634 million patent verdict Masimo won?
How will Danaher's $9.9 billion acquisition of Masimo reshape this legal war with Apple?
Did Masimo ultimately win by forcing Apple to offer a less integrated health feature?
Is this ruling a blueprint for tech giants to legally sidestep patents from smaller innovators?
Does moving health data processing to an iPhone create new performance or privacy risks?